Literature DB >> 15923239

Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease.

W D-C Man1, N S Hopkinson, F Harraf, D Nikoletou, M I Polkey, J Moxham.   

Abstract

BACKGROUND: Quadriceps muscle weakness is common in chronic obstructive pulmonary disease (COPD) but is not observed in a small hand muscle (adductor pollicis). Although this could be explained by reduced activity in the quadriceps, the observation could also be explained by anatomical location of the muscle or fibre type composition. However, the abdominal muscles are of a similar anatomical and fibre type distribution to the quadriceps, although they remain active in COPD. Cough gastric pressure is a recently described technique that assesses abdominal muscle (and hence expiratory muscle) strength more accurately than traditional techniques. A study was undertaken to test the hypothesis that more severe weakness exists in the quadriceps than in the abdominal muscles of patients with COPD compared with healthy elderly controls.
METHODS: Maximum cough gastric pressure and quadriceps isometric strength were measured in 43 patients with stable COPD and 25 healthy elderly volunteers matched for anthropometric variables.
RESULTS: Despite a significant reduction in mean quadriceps strength (29.9 kg v 41.2 kg; 95% CI -17.9 to -4.6; p = 0.001), cough gastric pressure was preserved in patients with COPD (227.3 cm H(2)O v 204.8 cm H(2)O; 95% CI -5.4 to 50.6; p = 0.11).
CONCLUSIONS: Abdominal muscle strength is preserved in stable COPD outpatients in the presence of quadriceps weakness. This suggests that anatomical location and fibre type cannot explain quadriceps weakness in COPD. By inference, we conclude that disuse and consequent deconditioning are important factors in the development of quadriceps muscle weakness in COPD patients, or that activity protects the abdominal muscles from possible systemic myopathic processes.

Entities:  

Mesh:

Year:  2005        PMID: 15923239      PMCID: PMC1747513          DOI: 10.1136/thx.2005.040709

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  37 in total

1.  Specific expiratory muscle training in COPD.

Authors:  Paltiel Weiner; Rasmi Magadle; Marinella Beckerman; Margalit Weiner; Noa Berar-Yanay
Journal:  Chest       Date:  2003-08       Impact factor: 9.410

2.  Expiratory muscle endurance in chronic obstructive pulmonary disease.

Authors:  A Ramírez-Sarmiento; M Orozco-Levi; E Barreiro; R Méndez; A Ferrer; J Broquetas; J Gea
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

3.  Nutritional status and muscle strength in patients with emphysema and severe alpha(1)-antitrypsin deficiency.

Authors:  Eeva Piitulainen; Johan Areberg; Mikael Lindén; Sten Eriksson; Sören Mattsson; Per Wollmer
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

4.  Relationship between respiratory muscle strength and lean body mass in men with COPD.

Authors:  Y Nishimura; M Tsutsumi; H Nakata; T Tsunenari; H Maeda; M Yokoyama
Journal:  Chest       Date:  1995-05       Impact factor: 9.410

5.  Cough gastric pressure and maximum expiratory mouth pressure in humans.

Authors:  William D-C Man; Dimitris Kyroussis; Tracey A Fleming; Alfredo Chetta; Farzaneh Harraf; Naveed Mustfa; Gerrard F Rafferty; Michael I Polkey; John Moxham
Journal:  Am J Respir Crit Care Med       Date:  2003-07-11       Impact factor: 21.405

6.  Catabolic/anabolic balance and muscle wasting in patients with COPD.

Authors:  Richard Debigaré; Karine Marquis; Claude H Côté; Roland R Tremblay; Annie Michaud; Pierre LeBlanc; François Maltais
Journal:  Chest       Date:  2003-07       Impact factor: 9.410

7.  Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects.

Authors:  Yvonne F Heijdra; Victor Pinto-Plata; Regina Frants; John Rassulo; Lawrence Kenney; Bartolome R Celli
Journal:  Chest       Date:  2003-07       Impact factor: 9.410

8.  Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease.

Authors:  W D-C Man; M G G Soliman; D Nikoletou; M L Harris; G F Rafferty; N Mustfa; M I Polkey; J Moxham
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

9.  Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients.

Authors:  A Couillard; C Koechlin; J P Cristol; A Varray; C Prefaut
Journal:  Eur Respir J       Date:  2002-11       Impact factor: 16.671

10.  Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.

Authors:  M A Spruit; R Gosselink; T Troosters; A Kasran; G Gayan-Ramirez; P Bogaerts; R Bouillon; M Decramer
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

View more
  17 in total

Review 1.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

2.  Impaired calcium signaling in muscle fibers from intercostal and foot skeletal muscle in a cigarette smoke-induced mouse model of COPD.

Authors:  Patrick Robison; Thomas E Sussan; Hegang Chen; Shyam Biswal; Martin F Schneider; Erick O Hernández-Ochoa
Journal:  Muscle Nerve       Date:  2017-02-13       Impact factor: 3.217

3.  Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease.

Authors:  Elisabeth B Swallow; Diana Reyes; Nicholas S Hopkinson; William D-C Man; Raphaël Porcher; Edward J Cetti; Alastair J Moore; John Moxham; Michael I Polkey
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

4.  Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease.

Authors:  Mark D Eisner; Carlos Iribarren; Edward H Yelin; Stephen Sidney; Patricia P Katz; Lynn Ackerson; Phenius Lathon; Irina Tolstykh; Theodore Omachi; Nancy Byl; Paul D Blanc
Journal:  Am J Epidemiol       Date:  2008-03-14       Impact factor: 4.897

5.  Abdominal muscle fatigue following exercise in chronic obstructive pulmonary disease.

Authors:  Nicholas S Hopkinson; Mark J Dayer; John Moxham; Michael I Polkey
Journal:  Respir Res       Date:  2010-02-04

Review 6.  Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients.

Authors:  Roberto A Rabinovich; Jordi Vilaró
Journal:  Curr Opin Pulm Med       Date:  2010-03       Impact factor: 3.155

7.  Daily activities are sufficient to induce dynamic pulmonary hyperinflation and dyspnea in chronic obstructive pulmonary disease patients.

Authors:  Antonio A M Castro; Claudia Kümpel; Rosana Chaves Rangueri; Maurício Dalcin Oliveira; Rodrigo Alves Dornelles; Emerson Roberto Brito; Tânia Maria Seki; Elias F Porto
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 8.  Muscle function in COPD: a complex interplay.

Authors:  Anna V Donaldson; Matthew Maddocks; Dario Martolini; Michael I Polkey; William D-C Man
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-08-17

9.  Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model.

Authors:  Lars Lüthje; Tobias Raupach; Hellmuth Michels; Bernhard Unsöld; Gerd Hasenfuss; Harald Kögler; Stefan Andreas
Journal:  Respir Res       Date:  2009-01-28

10.  Outpatient pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.

Authors:  Shahin Barakat; Germain Michele; Pastene George; Viallet Nicole; Annat Guy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.